Engineers Gate Manager’s Immunovant IMVT Stock Holding History

Engineers Gate Manager’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$215K	Buy	+8,660	New	+$224K	﹤0.01%	1877
2025 Q2	–	Sell	-26,720	Closed	-$457K	–	2336
2025 Q1	$457K	Sell	26,720 -9,017	-25%	-$189K	0.01%	1495
2024 Q4	$885K	Buy	+35,737	New	+$1.01M	0.02%	1087
2024 Q3	–	Sell	-13,564	Closed	-$358K	–	2238
2024 Q2	$358K	Buy	+13,564	New	+$386K	0.01%	1374
2024 Q1	–	Sell	-8,451	Closed	-$356K	–	2089
2023 Q4	$356K	Buy	+8,451	New	+$311K	0.01%	1355
2023 Q3	–	Sell	-26,519	Closed	-$503K	–	1932
2023 Q2	$503K	Buy	+26,519	New	+$495K	0.02%	1031
2022 Q2	–	Sell	-14,300	Closed	-$79K	–	2061
2022 Q1	$79K	Buy	14,300 +567	+4%	+$3.53K	﹤0.01%	1735
2021 Q4	$117K	Buy	+13,733	New	+$113K	0.01%	1786

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Engineers Gate Manager's IMVT Position: Q1 2026 in Review

Engineers Gate Manager opened a new position in Immunovant (IMVT) in Q1 2026: 8,660 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #1877 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in IMVT as recently as Q1 2025.

Engineers Gate Manager first reported a position in IMVT in Q4 2021 and has held it in 8 quarters since. The position peaked at $885K in Q4 2024. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

Engineers Gate Manager held 8,660 shares of Immunovant worth $215K as of Q1 2026.
Immunovant was a new Engineers Gate Manager position in Q1 2026.
Immunovant made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1877 holding.
Engineers Gate Manager first reported a position in Immunovant in Q4 2021 and has held it in 8 quarters since.
Engineers Gate Manager's Immunovant position peaked at $885K in Q4 2024.
215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.